Urothelial Carcinoma of the Bladder

Urothelial Carcinoma of the Bladder is a type of cancer that starts in the cells lining the inside of the bladder, which is an organ in the urinary system responsible for storing urine. This cancer mainly affects the bladder lining cells, causing abnormal growth that can form tumors. It often leads to symptoms like blood in the urine, pain during urination, and frequent urination. The disease can impact how well the bladder functions and may spread to other parts of the body if untreated. Early detection is important because treatment options vary depending on how deeply the cancer has invaded the bladder wall. Risk factors include smoking and exposure to certain chemicals. Understanding this condition helps in recognizing symptoms and seeking medical evaluation.

Urothelial Carcinoma of the Bladder is a malignant neoplasm arising from the urothelial cells that line the bladder mucosa. It is the most common type of bladder cancer and is primarily caused by carcinogen exposure, especially from tobacco smoke and industrial chemicals like aromatic amines. The tumor typically begins as a papillary or flat lesion confined to the mucosa or submucosa but can invade the muscularis propria and beyond, leading to worse prognosis. Histologically, it shows transitional cell features with variable degrees of differentiation. Clinically, it presents with painless hematuria and irritative voiding symptoms. The disease is significant due to its high recurrence rate and potential for progression to muscle-invasive cancer, which requires more aggressive treatment. Molecular alterations often involve mutations in genes such as FGFR3 and TP53.